Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus.

Jansen A, Türck M, Szekat C, Nagel M, Clever I, Bierbaum G.

Int J Med Microbiol. 2007 Jul;297(4):205-15. Epub 2007 Apr 5.

PMID:
17418637
2.

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus.

Cui L, Tominaga E, Neoh HM, Hiramatsu K.

Antimicrob Agents Chemother. 2006 Mar;50(3):1079-82.

3.

Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Cui L, Iwamoto A, Lian JQ, Neoh HM, Maruyama T, Horikawa Y, Hiramatsu K.

Antimicrob Agents Chemother. 2006 Feb;50(2):428-38.

4.

Allelic replacement in Staphylococcus aureus with inducible counter-selection.

Bae T, Schneewind O.

Plasmid. 2006 Jan;55(1):58-63. Epub 2005 Jul 26.

PMID:
16051359
5.

DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.

Cui L, Lian JQ, Neoh HM, Reyes E, Hiramatsu K.

Antimicrob Agents Chemother. 2005 Aug;49(8):3404-13.

7.

tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus.

Maki H, McCallum N, Bischoff M, Wada A, Berger-Bächi B.

Antimicrob Agents Chemother. 2004 Jun;48(6):1953-9.

8.

Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus.

Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K.

Mol Microbiol. 2003 Aug;49(3):807-21.

9.

Inactivation of mprF affects vancomycin susceptibility in Staphylococcus aureus.

Ruzin A, Severin A, Moghazeh SL, Etienne J, Bradford PA, Projan SJ, Shlaes DM.

Biochim Biophys Acta. 2003 May 2;1621(2):117-21.

PMID:
12726988
10.

Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K.

J Clin Microbiol. 2003 Jan;41(1):5-14.

11.

New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community.

Hiramatsu K, Okuma K, Ma XX, Yamamoto M, Hori S, Kapi M.

Curr Opin Infect Dis. 2002 Aug;15(4):407-13. Review.

PMID:
12130938
12.

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Hiramatsu K.

Lancet Infect Dis. 2001 Oct;1(3):147-55. Review.

PMID:
11871491
13.

Whole genome sequencing of meticillin-resistant Staphylococcus aureus.

Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, Lian J, Ito T, Kanamori M, Matsumaru H, Maruyama A, Murakami H, Hosoyama A, Mizutani-Ui Y, Takahashi NK, Sawano T, Inoue R, Kaito C, Sekimizu K, Hirakawa H, Kuhara S, Goto S, Yabuzaki J, Kanehisa M, Yamashita A, Oshima K, Furuya K, Yoshino C, Shiba T, Hattori M, Ogasawara N, Hayashi H, Hiramatsu K.

Lancet. 2001 Apr 21;357(9264):1225-40.

PMID:
11418146
14.

Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance.

Bischoff M, Roos M, Putnik J, Wada A, Glanzmann P, Giachino P, Vaudaux P, Berger-Bächi B.

FEMS Microbiol Lett. 2001 Jan 1;194(1):77-82.

15.

Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K.

Antimicrob Agents Chemother. 2000 Sep;44(9):2276-85.

16.
17.

Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50.

Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K.

J Antimicrob Chemother. 1998 Aug;42(2):199-209.

PMID:
9738837
18.

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I.

Lancet. 1997 Dec 6;350(9092):1670-3.

PMID:
9400512
20.

Supplemental Content

Support Center